DMK Pharmaceuticals Corporation Common Stock
DMK was delisted on the 6th of February, 2024.
28 hedge funds and large institutions have $10.6M invested in DMK Pharmaceuticals Corporation Common Stock in 2015 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 7 increasing their positions, 6 reducing their positions, and 4 closing their positions.
17% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 6
3% less capital invested
Capital invested by funds: $10.9M → $10.6M (-$316K)
3% less funds holding
Funds holding: 29 → 28 (-1)
25% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 4
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Sio Capital Management
New York
|
+$336K |
| 2 |
Northern Trust
Chicago,
Illinois
|
+$141K |
| 3 |
HighTower Advisors
Chicago,
Illinois
|
+$126K |
| 4 |
VKH
Virtu KCG Holdings
New York
|
+$40.7K |
| 5 |
Walleye Trading
New York
|
+$39.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MSU
Mizuho Securities USA
New York
|
-$87K |
| 2 |
Goldman Sachs
New York
|
-$50.1K |
| 3 |
EEG
E.E. Geduld
|
-$42K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$19.8K |
| 5 |
WA
WFG Advisors
Dallas,
Texas
|
-$17K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
| $1 | – | – | – |
|
|
MSU
27
Mizuho Securities USA
New York
| – | -$87K | -297 | Closed |
|
|
EEG
28
E.E. Geduld
| – | -$42K | -143 | Closed |
|
|
WA
29
WFG Advisors
Dallas,
Texas
| – | -$17K | -57 | Closed |
|
|
AIG
30
American International Group
New York
| – | -$14.3K | -49 | Closed |
|
31
Creative Planning
Overland Park,
Kansas
| – | +$278 | +1 | New |
|
DMK Hedge Fund Activity: Q3 2015 in Review
28 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in DMK Pharmaceuticals Corporation Common Stock (DMK) for Q3 2015, worth a combined $10.6M — down 2.9% from $10.9M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of DMK and 3 opened new positions — a net loss of 1 holder — while 6 trimmed existing stakes and 7 added.
The largest buyer was Sio Capital Management, adding an estimated $336K. The largest seller was Mizuho Securities USA, exiting entirely with an estimated $87K sold.
- 28 institutional investors held DMK Pharmaceuticals Corporation Common Stock (DMK) as of Q3 2015, down from 29 in Q2 2015.
- Funds reported $10.6M of DMK Pharmaceuticals Corporation Common Stock stock for Q3 2015, down 2.9% quarter-over-quarter.
- 3 funds opened new DMK Pharmaceuticals Corporation Common Stock positions in Q3 2015 and 4 closed out, a net change of -1 holder.
- The largest DMK Pharmaceuticals Corporation Common Stock buyer in Q3 2015 was Sio Capital Management, an estimated $336K added.
- The largest DMK Pharmaceuticals Corporation Common Stock seller in Q3 2015 was Mizuho Securities USA, an estimated $87K sold.
Based on aggregated 13F filings for Q3 2015.